Crinetics Pharmaceuticals Inc’s recent filing unveils that its President & CEO Struthers Richard Scott unloaded Company’s shares for reported $2.01 million on Apr 04 ’24. In the deal valued at $49.17 per share,40,951 shares were sold. As a result of this transaction, Struthers Richard Scott now holds 237,835 shares worth roughly $11.05 million.
Then, Okey Stephanie sold 17,500 shares, generating $811,650 in total proceeds. Upon selling the shares at $46.38, the Director now owns 6,000 shares.
Before that, Knight Jeff E. sold 32,359 shares. Crinetics Pharmaceuticals Inc shares valued at $1,433,675 were divested by the Chief Operating Officer at a price of $44.31 per share. As a result of the transaction, Knight Jeff E. now holds 52,580 shares, worth roughly $2.44 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Monday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock fall -2.29% to $46.44. Over the last five days, the stock has lost -0.19%. Crinetics Pharmaceuticals Inc shares have risen nearly 30.52% since the year began. Nevertheless, the stocks have risen 191.16% over the past one year. While a 52-week high of $49.58 was reached on 04/04/24, a 52-week low of $15.50 was recorded on 01/05/24. SMA at 50 days reached $40.95, while 200 days put it at $30.13. A total of 0.55 million shares were traded, compared to the trading of 2.91 million shares in the previous session.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 45.36, which if violated will result in even more drops to 44.27. On the upside, there is a resistance level at 47.92. A further resistance level may holdings at 49.39. The Relative Strength Index (RSI) on the 14-day chart is 58.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.27, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.62%. Stochastics %K at 74.70% indicates the stock is a holding.
How much short interest is there in Crinetics Pharmaceuticals Inc?
A steep rise in short interest was recorded in Crinetics Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 0.5 million shares to a total of 5.01 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 4.51 million shares. There was a rise of 9.98%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.05% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.97.
